Cytotoxic Effects of Chemokine Receptor 4 Inhibition by AMD3100 in Biliary Tract Cancer Cells: Potential Drug Synergism With Gemcitabine

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2015.3589
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Biweekly Cisplatin and Gemcitabine in Patients With Advanced Biliary Tract Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Chemokine (C-X-C Motif) Receptor 4 Blockade by AMD3100 Inhibits Experimental Abdominal Aortic Aneurysm Expansion Through Anti-Inflammatory Effects

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2014English

Tumor Growth Effects of Rapamycin on Human Biliary Tract Cancer Cells

European Journal of Medical Research
Medicine
2012English

Cost-Effectiveness of Gemcitabine Plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Irinotecan Plus Gemcitabine and Fluorouracil in Advanced Biliary Tract Cancer: A Retrospective Study

Digestion
Gastroenterology
2016English

Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer

HPB
HepatologyGastroenterology
2016English

A Case of Advanced Biliary Tract Cancer Successfully Treated With Single-Agent Gemcitabine Chemotherapy in Combination With Juzentaihoto

Kampo Medicine
2012English

Combination Therapy With Gossypol Reveals Synergism Against Gemcitabine Resistance in Cancer Cells With High BCL-2 Expression

PLoS ONE
Multidisciplinary
2012English

A Multicenter Phase II Study of S-1 for Gemcitabine-Refractory Biliary Tract Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy